These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 9330995)

  • 1. Current diagnostic criteria for assessment of neuropathological Alzheimer's disease.
    Gambetti P
    Neurobiol Aging; 1997; 18(4 Suppl):S95-6. PubMed ID: 9330995
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Validation of the Short Cognitive Battery (B2C). Value in screening for Alzheimer's disease and depressive disorders in psychiatric practice].
    Robert PH; Schuck S; Dubois B; Lépine JP; Gallarda T; Olié JP; Goni S; Troy S
    Encephale; 2003; 29(3 Pt 1):266-72. PubMed ID: 12876552
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Accurate prediction of histologically confirmed Alzheimer's disease and the differential diagnosis of dementia: the use of NINCDS-ADRDA and DSM-III-R criteria, SPECT, X-ray CT, and APO E4 medial temporal lobe dementias. The Oxford Project to Investigate Memory and Aging.
    Jobst KA; Barnetson LP; Shepstone BJ
    Int Psychogeriatr; 1997; 9 Suppl 1():191-222; discussion 247-52. PubMed ID: 9447442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cognitive differences in dementia patients with autopsy-verified AD, Lewy body pathology, or both.
    Kraybill ML; Larson EB; Tsuang DW; Teri L; McCormick WC; Bowen JD; Kukull WA; Leverenz JB; Cherrier MM
    Neurology; 2005 Jun; 64(12):2069-73. PubMed ID: 15985574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does executive impairment define a frontal variant of Alzheimer's disease?
    Woodward M; Brodaty H; Boundy K; Ames D; Blanch G; Balshaw R;
    Int Psychogeriatr; 2010 Dec; 22(8):1280-90. PubMed ID: 20719041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of common neuropathologies on progression of late life cognitive impairment.
    Yu L; Boyle PA; Leurgans S; Schneider JA; Kryscio RJ; Wilson RS; Bennett DA
    Neurobiol Aging; 2015 Jul; 36(7):2225-2231. PubMed ID: 25976345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Depressive symptoms increase the likelihood of cognitive impairment in elderly people with subclinical Alzheimer pathology.
    Milwain EJ; Nagy Z
    Dement Geriatr Cogn Disord; 2005; 19(1):46-50. PubMed ID: 15383746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Utility of combinations of biomarkers, cognitive markers, and risk factors to predict conversion from mild cognitive impairment to Alzheimer disease in patients in the Alzheimer's disease neuroimaging initiative.
    Gomar JJ; Bobes-Bascaran MT; Conejero-Goldberg C; Davies P; Goldberg TE;
    Arch Gen Psychiatry; 2011 Sep; 68(9):961-9. PubMed ID: 21893661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Awareness disorders in Alzheimer's disease and in mild cognitive impairment].
    Jacus JP; Dupont MP; Herades Y; Pelix C; Large H; Baud M
    Encephale; 2014 Apr; 40(2):180-7. PubMed ID: 24630532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cognitive functioning in late-life schizophrenia: a comparison of elderly schizophrenic patients and patients with Alzheimer's disease.
    Davidson M; Harvey P; Welsh KA; Powchik P; Putnam KM; Mohs RC
    Am J Psychiatry; 1996 Oct; 153(10):1274-9. PubMed ID: 8831434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of quantitative structural imaging in the early diagnosis of Alzheimer's disease.
    Glodzik-Sobanska L; Rusinek H; Mosconi L; Li Y; Zhan J; de Santi S; Convit A; Rich K; Brys M; de Leon MJ
    Neuroimaging Clin N Am; 2005 Nov; 15(4):803-26, x. PubMed ID: 16443492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined Analysis of CSF Tau Levels and [(123)I]Iodoamphetamine SPECT in Mild Cognitive Impairment: Implications for a Novel Predictor of Alzheimer's Disease.
    Okamura N; Arai H; Maruyama M; Higuchi M; Matsui T; Tanji H; Seki T; Hirai H; Chiba H; Itoh M; Sasaki H
    Am J Psychiatry; 2002 Mar; 159(3):474-6. PubMed ID: 11870015
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current evidence for subjective cognitive impairment (SCI) as the pre-mild cognitive impairment (MCI) stage of subsequently manifest Alzheimer's disease.
    Reisberg B; Gauthier S
    Int Psychogeriatr; 2008 Feb; 20(1):1-16. PubMed ID: 18072981
    [No Abstract]   [Full Text] [Related]  

  • 14. Neuropathological criteria for the diagnosis of Alzheimer's disease.
    Markesbery WR
    Neurobiol Aging; 1997; 18(4 Suppl):S13-9. PubMed ID: 9330980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preclinical Alzheimer's disease: diagnosis and prediction of progression.
    Chong MS; Sahadevan S
    Lancet Neurol; 2005 Sep; 4(9):576-9. PubMed ID: 16109364
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Volumetric MRI vs clinical predictors of Alzheimer disease in mild cognitive impairment.
    Fleisher AS; Sun S; Taylor C; Ward CP; Gamst AC; Petersen RC; Jack CR; Aisen PS; Thal LJ
    Neurology; 2008 Jan; 70(3):191-9. PubMed ID: 18195264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathologic and nicotinic receptor binding differences between mild cognitive impairment, Alzheimer disease, and normal aging.
    Sabbagh MN; Shah F; Reid RT; Sue L; Connor DJ; Peterson LK; Beach TG
    Arch Neurol; 2006 Dec; 63(12):1771-6. PubMed ID: 17172618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Olfactory function in mild cognitive impairment and Alzheimer's disease: an investigation using psychophysical and electrophysiological techniques.
    Peters JM; Hummel T; Kratzsch T; Lötsch J; Skarke C; Frölich L
    Am J Psychiatry; 2003 Nov; 160(11):1995-2002. PubMed ID: 14594747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subtle Cognitive Decline and Biomarker Staging in Preclinical Alzheimer's Disease.
    Edmonds EC; Delano-Wood L; Galasko DR; Salmon DP; Bondi MW;
    J Alzheimers Dis; 2015; 47(1):231-42. PubMed ID: 26402771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alzheimer's Disease Assessment Scale-Cognitive subscale variants in mild cognitive impairment and mild Alzheimer's disease: change over time and the effect of enrichment strategies.
    Podhorna J; Krahnke T; Shear M; Harrison JE;
    Alzheimers Res Ther; 2016 Feb; 8():8. PubMed ID: 26868820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.